Cork-based MicroSynbiotix secures €1m to tackle fish stock infections

Biotech intends to take on additional staff in Cork city following the funding boost

MicroSynbiotiX co-founders Antonio Lamb and Simon Jegan Porphy

MicroSynbiotiX co-founders Antonio Lamb and Simon Jegan Porphy

MicroSynbiotiX, a Cork-based biotech start-up that is developing oral vaccines to help combat infections in fish stocks, has secured €1 million in seed funding from investors which include entrepreneur Sean O’Sullivan’s SOSV.

Established in April 2016 by Simon Jegan Porphy and Antonio Lamb, the company is a former participant in RebelBio, the life sciences accelerator programme established by SOSV in Cork city.

Please subscribe or sign in to continue reading.
only €1 first month

Insightful opinion is just a away.